Abstract
Background: The aspirin exacerbated respiratory disease (AERD) shows a prevalence of 7% among asthmatics and increases to 14% in patients with difficult to control asthma. Treatment includes the use of inhibitors of leukotriene receptor (), intranasal steroids, polypectomy, asthma management according to the severity and avoid taking nonsteroidal anti-inflammatory drugs (NSAIDs). In some patients it is necessary desensitization protocol to it.
Clinical cases: two patients diagnosed with respiratory disease exacerbated by aspirin, with poor asthma control and need for multiple polypectomies, despite optimal pharmacological management, carrying out protocol desensitization to aspirin (AAS) successful, now after 4 years of having carried out, they have adequate asthma control without need for polypectomies with a maintenance dose of aspirin 150 mg/day.
References
Marek L. Kowalski, Classification of Reactions to Nonsteroidal Antiinflammatory Drugs. Immunol Allergy Clin N Am 2013, 33:135–145.
Laidlaw, T. Aspirin- Exacerbated Respiratory Disease. Up To Date, 2015; 1-20.
Rajan JP. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. J Allergy Clin Immunol 2015; 135:676.
Laidlaw, T. Pathogenesis of Aspirin-Exacerbated Respiratory Disease and Reactions. Immunol Allergy Clin N Am. 2013:33;195-210.
Bochenek, G. Aspirin-Exacerbated Respiratory Disease: Clinical Disease and Diagnosis. Immunol Allergy Clin N Am, 2013, 33:147-161.
Simon, R. Aspirin-Exacerbated Respiratory Disease: nSAID Challenge And Desensitization. Up To Date, 2014; 1-14.
Diario Oficial IMSS, 2015: 1-4.
Alvarez-Puebla, M. Inhibidores de la COX-2 en la enfermedad respiratoria exacerbada por aspirina. Alergol Inmunol Clin 2004; 19: 39-40
Lee J. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007; 119:157.
Świerczyńska-K. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a doubleblind study. J Allergy Clin Immunol 2014; 134:883.
Cho KS, Soudry E, Psaltis AJ, et al. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease. Otolaryngol Head Neck Surg 2014; 151:575.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2016 Revista Alergia México